Lv1
100 积分 2024-10-18 加入
Resmetirom: First Approval
1个月前
已完结
Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis
1个月前
已完结
Super-dosed butyrate induces a revisable metabolic paralysis through transient mitochondrial reprogramming in the gut-brain axis
3个月前
已关闭
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist #
4个月前
已完结
Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1
5个月前
已完结
Elafibranor and nitazoxanide synergize to reduce fibrosis in a NASH model
5个月前
已完结
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
5个月前
已完结
Basal Metabolic Rate and Thyroid Hormones
7个月前
已关闭
Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies
7个月前
已完结
“Mild” Uncoupling of Mitochondria
7个月前
已完结
Assessing antimicrobial resistance connectivity across One Health sectors
皖公网安备34019202002308
